نتائج البحث - Khunger, Arjun
- يعرض 1 - 17 نتائج من 17
-
1
-
2
-
3
Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience حسب Khunger, Arjun, Khunger, Monica, Velcheti, Vamsidhar
منشور في 2018نص -
4
-
5
-
6
-
7
-
8
The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients حسب Khunger, Arjun, Rytlewski, Julie A., Fields, Paul, Yusko, Erik C., Tarhini, Ahmad A.
منشور في 2019نص -
9
-
10
-
11
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma حسب Khunger, Arjun, Sarikonda, Ghanashyam, Tsau, Jennifer, Pahuja, Anil, Alfonso, Zeni, Gao, Jane, Laing, Christian, Vaupel, Christine, Dakappagari, Naveen, Tarhini, Ahmad A.
منشور في 2021نص -
12
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature حسب Agrawal, Nikhil, Khunger, Arjun, Vachhani, Pankit, Colvin, Teresa A., Hattoum, Alexander, Spangenthal, Edward, Curtis, Anne B., Dy, Grace K., Ernstoff, Marc S., Puzanov, Igor
منشور في 2019نص -
13
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients حسب Khunger, Monica, Patil, Pradnya Dinkar, Khunger, Arjun, Li, Manshi, Hu, Bo, Rakshit, Sagar, Basu, Arnab, Pennell, Nathan, Stevenson, James P., Elson, Paul, Panchabhai, Tanmay S., Velcheti, Vamsidhar
منشور في 2018نص -
14
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma حسب Khunger, Arjun, Piazza, Erin, Warren, Sarah, Smith, Thomas H., Ren, Xing, White, Andrew, Elliott, Nathan, Cesano, Alessandra, Beechem, Joseph M., Kirkwood, John M., Tarhini, Ahmad A.
منشور في 2021نص -
15
NCOG-27. INCREASED OVERALL SURVIVAL AMONG RACIAL MINORITIES AND SUBOPTIMAL USE OF STANDARD OF CARE TREATMENT IN GLIOBLASTOMA MULTIFORME حسب Boisclair, Stephanie, Samuels, Shenae, Khunger, Arjun, Wietecha, Delia A, Cohen, Alejandro Lopez, King, Kelly, Sareli, Candice, Jacques, Jessica, Salzberg, Mathew, Vulfovich, Michel, Hunis, Brian, Raez, Luis E, Hussein, Atif M
منشور في 2020نص -
16
NCOG-34. AN ASSESSMENT OF OVERALL SURVIVAL AND PALLIATIVE CARE USE AMONG PATIENTS WITH GLIOSARCOMA DIAGNOSED OVER A TWELVE-YEAR SPAN حسب Boisclair, Stephanie, Samuels, Shenae, Raez, Luis E, Wietecha, Delia A, Cohen, Alejandro Lopez, Khunger, Arjun, King, Kelly, Sareli, Candice, Adames, Jorges, Jacques, Jessica, Salzberg, Mathew, Hunis, Brian, Vulfovich, Michel, Hussein, Atif M
منشور في 2020نص -
17
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis حسب Puzanov, Igor, Subramanian, Poornima, Yatsynovich, Yan V, Jacobs, David M, Chilbert, Maya R, Sharma, Umesh C, Ito, Fumito, Feuerstein, Steven G, Stefanovic, Filip, Switzer, Benjamin, Hicar, Mark D, Curtis, Anne B, Spangenthal, Edward J, Dy, Grace K, Ernstoff, Marc S, Vachhani, Pankit, Page, Brian J, Agrawal, Nikhil, Khunger, Arjun, Kapoor, Ankita, Hattoum, Alexander, Schentag, Jerome J
منشور في 2021نص